Nebraska Cancer Specialists · 1 day ago
Patient Financial Advocate- Omaha, NE
Nebraska Cancer Specialists is the regional leader in cancer diagnosis, treatment and research, seeking a Patient Financial Advocate. This role is responsible for helping patients navigate treatment costs and options for assistance, meeting with patients to discuss their financial responsibilities and available resources.
BiotechnologyHealth CareMedicalOncology
Responsibilities
Meets with new treatment patients that are self-pay, to review cost of care and avenues for patient assistance
Collaborates with the precertification team to identify patients eligible for co-pay cards, Foundations, Societies or who might qualify for drug replacement
Maintains an accurate record of all patients receiving assistance as above
Works with patients to complete hardship applications and follows practice policy for hardship and write off
Meets with patients to discuss outstanding balances and determines plan for payment
Demonstrates NCS Mission and Core Values through actions and words
Ability to work in a fast-paced environment and demonstrates flexibility and adaptability
Qualification
Required
One year of Medicare, Medicaid and commercial insurance billing
Excellent computer skills, including Microsoft Office, Word, Excel and Outlook
Ability to meet deadlines and work with minimum supervision
High school diploma or GED required
Excellent verbal and written communication skills
Ability to read, speak, write, and understand the English language fluently
Preferred
Previous experience working in a medical office is preferred
bilingual a plus (English/Spanish)
Benefits
Affordable health, vision, and dental insurance
Long-term disability
Life insurance
401K
Flex spending
Employee Assistance Program
Generous paid time off plan including holidays and birthday
Company
Nebraska Cancer Specialists
Nebraska Cancer Specialists is a healthcare company that provides medical oncology, radiation oncology, and hematology services.
Funding
Current Stage
Growth StageRecent News
2025-01-09
2024-03-21
Company data provided by crunchbase